Stress Ii Liquid
NDC Package 81825-0011-1
Package Information
Stress Ii (epinephrine, thyroid, unspecified, bos taurus pituitary gland, posterior, arsenic trioxide, oyster shell calcium carbonate, crude, conium maculatum flowering top, cortisone acetate, crotalus horridus horridus venom, iron, strychnos nux-vomica seed, phosphoric acid, phosphorus, selenium, sepia officinalis juice, and zanthoxylum americanum bark) liquids is adults & children above 12 years: 10 drops orally 3 times daily, or as directed by a health care professional. This formulation utilizes a liquid delivery system. Marketed by Zorex, this product is identified by NDC 81825-0011.
Identification & Billing
Clinical Specifications
- ARSENIC TRIOXIDE 12 [hp_X]/mL
- BOS TAURUS PITUITARY GLAND, POSTERIOR 9 [hp_X]/mL
- CONIUM MACULATUM FLOWERING TOP 12 [hp_X]/mL
- CORTISONE ACETATE 12 [hp_X]/mL
- CROTALUS HORRIDUS HORRIDUS VENOM 12 [hp_X]/mL
- EPINEPHRINE 9 [hp_X]/mL
- IRON 12 [hp_X]/mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X]/mL
- PHOSPHORIC ACID 12 [hp_X]/mL
- PHOSPHORUS 12 [hp_X]/mL
- SELENIUM 12 [hp_X]/mL
- SEPIA OFFICINALIS JUICE 12 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED 12 [hp_X]/mL
- THYROID, UNSPECIFIED 9 [hp_X]/mL
- ZANTHOXYLUM AMERICANUM BARK 30 [hp_X]/mL
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Adrenergic beta-Agonists - [MoA] (Mechanism of Action)
- Allergens - [CS]
- Catecholamine - [EPC] (Established Pharmacologic Class)
- Catecholamines - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Corticosteroid Hormone Receptor Agonists - [MoA] (Mechanism of Action)
- Corticosteroid - [EPC] (Established Pharmacologic Class)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
- beta-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 81825 - Zorex
- 81825-0011 - Stress Ii
- 81825-0011-1 - 30 mL in 1 BOTTLE, DROPPER
- 81825-0011 - Stress Ii
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 81825-0011-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Stress Ii, a human over the counter drug labeled by Zorex. This liquid is formulated for oral use and contains arsenic trioxide; bos taurus pituitary gland, posterior; conium maculatum flowering top; cortisone acetate; crotalus horridus horridus venom; epinephrine; iron; oyster shell calcium carbonate, crude; phosphoric acid; phosphorus; selenium; sepia officinalis juice; strychnos nux-vomica seed; thyroid, unspecified; zanthoxylum americanum bark as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zorex on June 16, 2025. The current certification is valid through December 31, 2026.
How is this Zorex product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 81825001101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.